Differential binding properties of oripavines at cloned μ- and δ-opioid receptors

被引:91
作者
Lee, KO
Akil, H
Woods, JH
Traynor, JR
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA
关键词
oripavine; opioid receptor; ligand binding; efficacy; buprenorphine; etorphine;
D O I
10.1016/S0014-2999(99)00460-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study examines the possibility that oripavine opioid receptor agonists bind equally to both high and low affinity states of the mu-opioid receptor. Studies were performed in C6 cells expressing mu- or delta-opioid receptors; high and low agonist affinity states of the receptors were defined by the absence and presence, respectively of Na+ ions and the GTP analog Gpp(NH)p. At the mu-opioid receptor dihydroetorphine and etorphine were full agonists, buprenorphine had moderate efficacy while diprenorphine was an antagonist. At the delta-opioid receptor, dihydroetorphine, etorphine, and diprenorphine had moderate efficacy while buprenorphine was an antagonist. The binding affinities of the oripavines at the mu-opioid receptor decreased only one to 2-fold in the presence of NaCl and Gpp(NH)p. In contrast, decreases in oripavine affinity at the delta-opioid receptor correlated with delta-opioid receptor efficacy. The ability of oripavine agonists to bind with high affinity to the low agonist affinity state of the v-opioid receptor may explain the high potencies of these compounds in vivo. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 42 条
[1]  
Alt A, 1998, J PHARMACOL EXP THER, V286, P282
[2]   RECEPTOR-EFFECTOR COUPLING BY G-PROTEINS [J].
BIRNBAUMER, L ;
ABRAMOWITZ, J ;
BROWN, AM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1031 (02) :163-224
[3]   ACTIONS OF ETORPHINE HYDROCHLORIDE (M99) - A POTENT MORPHINE LIKE AGENT [J].
BLANE, GF ;
BOURA, ALA ;
FITZGERALD, AE ;
LISTER, RE .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 30 (01) :11-+
[4]  
Bot G, 1998, J NEUROCHEM, V70, P358
[5]   THE PHYSIOLOGICAL RELEVANCE OF LOW AGONIST AFFINITY BINDING AT OPIOID MU-RECEPTORS [J].
CARROLL, JA ;
SHAW, JS ;
WICKENDEN, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :625-631
[6]  
CHENG YC, 1973, BIOCHEM PHARMACOL, V22, P2745
[7]   DIFFERENTIAL REGULATION BY GUANINE-NUCLEOTIDES OF OPIATE AGONIST AND ANTAGONIST RECEPTOR INTERACTIONS [J].
CHILDERS, SR ;
SNYDER, SH .
JOURNAL OF NEUROCHEMISTRY, 1980, 34 (03) :583-593
[8]  
CHILDERS SR, 1993, MOL PHARMACOL, V44, P827
[9]  
Clark MJ, 1997, J PHARMACOL EXP THER, V283, P501
[10]   ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT [J].
COWAN, A ;
DOXEY, JC ;
HARRY, EJR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :547-554